fashion -WSS

fashion

author：entertainment 2025-10-01 17:21:20 - browse：892

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease.

For more on what we cover, here’s more on Amylyx; here’s the story on hemophilia gene therapy; here’s the news on Madrigal Pharmaceuticals’ drug for MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

focus

WSS

Will the IRA bring competition to the biologics market?

Illumina board agrees to spin off Grail, as divestment plans proceed

What to make of Biden’s latest efforts on cancer research

BD to buy Edwards patient monitoring unit for $4.2 billion

New weight loss drugs vying to be the next Wegovy or Mounjaro

Telehealth for opioid use disorder is lifesaving

hotspot

fashion

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Data don't support strong claims for Covid

At least 13 dead in Texas as scorching temps continue

Food makers to regulators: Ultra

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare Advantage's lean provider networks lead CMS complaints

Alkermes shareholders re

FTC loses bid to block Novant's North Carolina hospital merger

Medical records are filled with copy

FDA approves updated Covid vaccines

explore

ASCO Daily Recap: CAR

A new initiative will help leaders fight the next pandemic

FTC loses bid to block Novant's North Carolina hospital merger

IRA could hurt research into orphan drugs for rare diseases

White House touts steps to stem shortages of cancer treatments

UnitedHealth CEO's Medicaid comments send insurer stocks diving

focus

entertainment

entertainment

focus